Targeted therapies in the management of colorectal carcinoma: role of bevacizumab

por Puthillath, Ajithkumar, Patel, Anush, Fakih, Marwan G
Publicado 2009

Effects of prior therapies on outcomes with trifluridine/tipiracil in patients with metastatic gastric/gastroesophageal junction cancer in a randomized phase III trial (TAGS)

por Shitara, Kohei, George, Ben, Taieb, Julien, Sundar, Raghav, Fakih, Marwan G., Makris, Lukas, Benhadji, Karim A., Ghidini, Michele
Publicado 2023

Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic

por O’Leary, Michael P., Choong, Kevin C., Thornblade, Lucas W., Fakih, Marwan G., Fong, Yuman, Kaiser, Andreas M.
Publicado 2020

Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung Metastases

por Ye, Jian, Guo, Weihua, Wang, Chongkai, Egelston, Colt A., D'Apuzzo, Massimo, Shankar, Geereesh, Fakih, Marwan G., Lee, Peter P.
Publicado 2023

Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy

por Cao, Xu, Chen, Jing, Li, Bolei, Dang, Jessica, Zhang, Wencan, Zhong, Xiancai, Wang, Chongkai, Raoof, Mustafa, Sun, Zuoming, Yu, Jianhua, Fakih, Marwan G., Feng, Mingye
Publicado 2022

Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity

por Ma, Wen Wee, Saif, Muhammad Wasif, El‐Rayes, Bassel F., Fakih, Marwan G., Cartwright, Thomas H., Posey, James A., King, Thomas R., von Borstel, Reid W., Bamat, Michael K.
Publicado 2016

Serum Vitamin D Metabolites in Colorectal Cancer Patients Receiving Cholecalciferol Supplementation: Correlation with Polymorphisms in the Vitamin D Genes

por Muindi, Josephia R., Adjei, Araba A., Wu, Zengru R., Olson, Isabel, Huang, Huayi, Groman, Adrienne, Tian, Lili, Singh, Prashant K., Sucheston, Lara E., Johnson, Candace S., Trump, Donald L., Fakih, Marwan G.
Publicado 2013

Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial

por Mettu, Niharika B., Ou, Fang-Shu, Zemla, Tyler J., Halfdanarson, Thorvardur R., Lenz, Heinz-Josef, Breakstone, Rimini A., Boland, Patrick M., Crysler, Oxana V., Wu, Christina, Nixon, Andrew B., Bolch, Emily, Niedzwiecki, Donna, Elsing, Alicia, Hurwitz, Herbert I., Fakih, Marwan G., Bekaii-Saab, Tanios
Publicado 2022